Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/240913
Share/Export:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Siglec-1 on dendritic cells mediates SARS-CoV-2 trans-infection of target cells while on macrophages triggers proinflammatory responses

AuthorsPerez-Zsolt, Daniel; Muñoz-Basagoiti, Jordana; Rodón, Jordi; Elousa, Marc; Raïch-Regué, Dàlia; Risco, Cristina CSIC ORCID ; Sachse, Martín; Pino, María; Gumber, Sanjeev; Paiardini, Mirko; Chojnacki, Jakub; Erkizia, tziar; Muñiz-Trabudua, Xabier; Ballana, Ester; Riveira-Muñoz, Eva; Noguera, Marc; Paredes, Roger; Trinité, Benjamin; Tarrés-Freixas, Ferrán; Blanco, Ignacio; Guallar, Victor; Carrillo, Jorge; Blanco, Julià; Telenti, Amalio; Heyn, Holger; Segalés, Joaquim; Clotet, Bonaventura; Martínez-Picado, Javier; Vergara-Alert, Júlia; Izquierdo-Useros, Núria
Issue Date14-May-2021
PublisherBioRxiv
CitationBioRxiv: 10.1101/2021.05.11.443572 (2021)
AbstractCOVID-19 pandemic is not yet under control by vaccination, and effective antivirals are critical for preparedness. Here we report that macrophages and dendritic cells, key antigen presenting myeloid cells (APCs), are largely resistant to SARS-CoV-2 infection. APCs effectively captured viruses within cellular compartments that lead to antigen degradation. Macrophages sense SARS-CoV-2 and released higher levels of cytokines, including those related to cytokine storm in severe COVID-19. The sialic acid-binding Ig-like lectin 1 (Siglec-1/CD169) present on APCs, which interacts with sialylated gangliosides on membranes of retroviruses or filoviruses, also binds SARS-CoV-2 via GM1. Blockage of Siglec-1 receptors by monoclonal antibodies reduces SARS-CoV-2 uptake and transfer to susceptible target cells. APCs expressing Siglec-1 and carrying SARS-CoV-2 are found in pulmonary tissues of non-human primates. Single cell analysis reveals the in vivo induction of cytokines in those macrophages. Targeting Siglec-1 could offer cross-protection against SARS-CoV-2 and other enveloped viruses that exploit APCs for viral dissemination, including those yet to come in future outbreaks.
Publisher version (URL)https://doi.org/10.1101/2021.05.11.443572
URIhttp://hdl.handle.net/10261/240913
DOI10.1101/2021.05.11.443572
Appears in Collections:(PTI Salud Global) Colección Especial COVID-19
(CNB) Artículos

Files in This Item:
File Description SizeFormat
2021.05.11.443572v1.full.pdf5,93 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

CORE Recommender

Page view(s)

158
checked on Jul 19, 2024

Download(s)

141
checked on Jul 19, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons